By indication / Other radioligand therapy
Other radioligand therapy
3 imaging agents and 18 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [99mTc]Tc-PSMA-I&S | Tc-99m | — | 7 |
| [89Zr]Zr-DFO-girentuximab | Zr-89 | clinical proof-of-concept / prospective pilot study | 4 |
| [18F]fluorophenylalanine | F-18 | first-in-human |
Therapy
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [131I]MIBG paired with [123I]MIBG | I-131 | approved | 19 |
| [177Lu]Lu-pentixather paired with [68Ga]Ga-Pentixafor | Lu-177 | Investigational (first-in-human / early clinical) | 15 |
| [90Y]Y-pentixather | Y-90 | — | 9 |
| [177Lu]Lu-PP-F11N | Lu-177 | clinical trial (phase 0) | 7 |
| [225Ac]Ac-DOTA-YS5 | Ac-225 | preclinical study | 4 |
| [225Ac]Ac-Macropa-PEG4-YS5 | Ac-225 | — | 4 |
| [90Y]Y-90-FF-21101 | Y-90 | phase I/II clinical trial | 2 |
| [177Lu]Lu-AKIR001 | Lu-177 | phase 1 clinical trial | 2 |
| [177Lu]Lu-DOTA-DV1-K-DV3 | Lu-177 | — | 2 |
| [212Pb]Pb-DO3A-PEG7-Tz | Pb-212 | preclinical study | 2 |
| [225Ac]Ac-DOTA-CCK-66 paired with [68Ga]Ga-DOTA-CCK-66 | Ac-225 | preclinical study | 1 |
| [225Ac]Ac-DOTAZOL | Ac-225 | preclinical | 1 |
| [161Tb]Tb-BL02 | Tb-161 | preclinical study | 1 |
| [225Ac]Ac-mcp-TDI-Y-010 | Ac-225 | Reported once | 1 |
| [177Lu]Lu-DOTA-GA13 | Lu-177 | Reported once | 1 |
| [161Tb]Tb-cAC10 | Tb-161 | Reported once | 1 |
| [225Ac]Ac(MacropaSq-hG250) | Ac-225 | preclinical study | 1 |
| [177Lu]Lu-DTPA-NY003 | Lu-177 | preclinical study | 1 |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch